Ellenbecker Investment Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$982K Buy
5,290
+7
+0.1% +$1.3K 0.16% 40
2025
Q1
$1.11M Buy
5,283
+627
+13% +$131K 0.2% 38
2024
Q4
$827K Sell
4,656
-730
-14% -$130K 0.15% 49
2024
Q3
$1.06M Sell
5,386
-675
-11% -$133K 0.2% 42
2024
Q2
$1.04M Buy
6,061
+82
+1% +$14.1K 0.21% 39
2024
Q1
$1.09M Buy
5,979
+95
+2% +$17.3K 0.23% 38
2023
Q4
$911K Buy
5,884
+153
+3% +$23.7K 0.21% 42
2023
Q3
$854K Sell
5,731
-72
-1% -$10.7K 0.22% 40
2023
Q2
$781K Buy
5,803
+83
+1% +$11.2K 0.2% 43
2023
Q1
$911K Buy
5,720
+42
+0.7% +$6.69K 0.25% 35
2022
Q4
$917K Buy
5,678
+718
+14% +$116K 0.27% 34
2022
Q3
$665K Buy
4,960
+286
+6% +$38.3K 0.21% 35
2022
Q2
$715K Buy
4,674
+132
+3% +$20.2K 0.22% 34
2022
Q1
$736K Buy
4,542
+33
+0.7% +$5.35K 0.21% 36
2021
Q4
$610K Buy
4,509
+45
+1% +$6.09K 0.17% 36
2021
Q3
$481K Sell
4,464
-35
-0.8% -$3.77K 0.15% 39
2021
Q2
$507K Sell
4,499
-31
-0.7% -$3.49K 0.17% 34
2021
Q1
$490K Buy
4,530
+93
+2% +$10.1K 0.17% 38
2020
Q4
$475K Buy
4,437
+8
+0.2% +$856 0.18% 38
2020
Q3
$388K Buy
4,429
+72
+2% +$6.31K 0.17% 41
2020
Q2
$428K Buy
4,357
+171
+4% +$16.8K 0.21% 34
2020
Q1
$319K Buy
4,186
+5
+0.1% +$381 0.2% 37
2019
Q4
$370K Sell
4,181
-98
-2% -$8.67K 0.19% 39
2019
Q3
$324K Buy
4,279
+283
+7% +$21.4K 0.18% 43
2019
Q2
$291K Buy
3,996
+348
+10% +$25.3K 0.17% 45
2019
Q1
$294K Buy
3,648
+243
+7% +$19.6K 0.19% 47
2018
Q4
$314K Buy
+3,405
New +$314K 0.24% 40